YZi Labs Expands Focus with New Biotech Leader
YZi Labs, formerly known as Binance Labs, has appointed Jane He as a General Partner. This move signals the firm’s strategic shift towards biotechnology adn artificial intelligence, expanding beyond its traditional Web3 investments.
Jane he brings extensive experience in biotech and medtech. her expertise includes cancer therapies, gene editing, and AI-driven biotech solutions.Before joining YZi Labs, He was an investor and COO at a Hong Kong-based hedge fund, focusing on growth-stage biotech companies.
Ella Zhang, Head of YZi Labs, expressed enthusiasm about He’s appointment. “Jane’s talent and entrepreneurial spirit will help us explore interdisciplinary innovations. We’re excited to support transformative projects at the intersection of AI, biotech, and Web3.”
Biotech is advancing rapidly, with AI playing a crucial role in drug discovery and personalized medicine.YZi Labs aims to capitalize on these trends by investing in visionary founders driving technological advancements.
- YZi Labs expands into biotech and AI.
- jane He joins as General partner, bringing biotech expertise.
- The firm seeks innovations in Web3, AI, and biotech.
